Hope Against Cancer Provide New Funding For Research Into Lymphoblastic Leukaemia
Main Category: Lymphoma / Leukemia / MyelomaAlso Included In: Cancer / Oncology
Article Date: 28 Feb 2008 - 1:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A University of Leicester scientist has announced a major advance in understanding of a cancer that strikes at infants and young children.
The Leicestershire and Rutland charity Hope Against Cancer, currently celebrating its 5th anniversary, has now made funding available to further the research project at the University of Leicester investigating acute lymphoblastic leukaemia (ALL).
Professor Martin Dyer, in the University's Department of Cancer Studies and Molecular Medicine, has received £15,000 from Hope for consumables to aid his research.
Professor Dyer's team has recently identified a series of ten novel chromosomal translocations in children and young adults with acute lymphoblastic leukaemia. These translocations arise following breaks within DNA that are repaired incorrectly.
Chromosomal translocations play a pivotal role in the development of ALL. Their identification is useful in terms of understanding how the disease arises, in defining new subgroups of disease and ultimately may lead to the development of new targeted therapies.
Professor Dyer commented: "The identification of so many new chromosomal translocations in ALL is unexpected and is very exciting. It sheds fundamental new light on the pathogenesis of the disease. One translocation defines a subgroup of about 15% of patients that had previously lacked a molecular marker.
"Understanding how these events transform normal cells has now become a major goal of my laboratory. I am very grateful to the rapid response of Hope Against Cancer, which will allow us to pursue this development fully in a timely manner."
Some of the data relating to Professor Dyer's research has been presented to the American Society of Hematology.
Hope has already provided support for Professor Dyer's research in the form of a Clinical Research Fellowship to investigate various aspects of Chronic Lymphocytic Leukaemia (CLL)
This year Hope Against Cancer (formerly The Hope foundation for Cancer Research) is celebrating its fifth anniversary. Established in 2002, the Leicestershire and Rutland charity has grown in strength and now funds a significant number of cancer researchers in our local hospitals and universities.
Founded by the late Allison Wilson CBE, following the discovery that she had cancer, The Hope Foundation was set up to promote clinical trials, with all the benefits these bring to cancer care in the region.
Much of the research supported by Hope Against Cancer is based at the University of Leicester, where the charity funds PhD research posts, clinical fellowships, Allison Wilson Fellowships and this year, for the first time, a nursing fellowship. Projects include:
- research into proteins that may trigger cancer
- minimising the risks of chemotherapy and radiotherapy
- a bilberry derivative that may help prevent bowel and liver cancer
- the use of natural products to prevent colorectal and prostate cancers
- the targeting of treatments to suit individual cases
One of the region's consultant oncologists said: "I cannot emphasise enough how difficult it is to get funding to start any research project. In this regard, the Hope Foundation is completely invaluable in providing funding where we have good ideas, some preliminary data, but clearly not enough information yet to go for a big project grant.
"As a clinician, I therefore just want to emphasise how important these opportunities given to us by Hope are, both to promote cancer research in the region and to ensure that our patients really do benefit."
- Professor Martin J.S. Dyer MA DPhil FRCP FRCPath. Is Professor of Haemato-Oncology at the University of Leicester and Honorary Consultant Physician at University Hospitals of Leicester NHS Trust.
University Of Leicester
- A member of the 1994 Group of universities that share a commitment to research excellence, high quality teaching and an outstanding student experience.
- Ranked top for student satisfaction in England (jointly with Oxford) among mainstream universities (average score of 4.4 out of 5 for overall satisfaction)
- Ranked as a Top 20 university by The Sunday Times University Guide, The Guardian University Guide and the UK Good University Guide
- One of just 23 UK universities to feature in world's top 200- Shanghai Jiao Tong International Index, 2005-07.
- Ranked in top 200 world universities by the THES (Times Higher Education Supplement)
- Short listed University of the Year in 2007 by The Sunday Times and Short listed Higher Education Institution of the Year - THES awards 2005 and 2006
- Ranked top 10 in England for research impact by The Guardian
- Students' Union of the Year award 2005, short listed 2006 and 2007
Founded in 1921, the University of Leicester has 19,000 students from 136 countries. Teaching in 18 subject areas has been graded Excellent by the Quality Assurance Agency- including 14 successive scores - a consistent run of success matched by just one other UK University. Leicester is world renowned for the invention of DNA Fingerprinting by Professor Sir Alec Jeffreys and houses Europe's biggest academic Space Research Centre. 90% of staff are actively engaged in high quality research and 13 subject areas have been awarded the highest rating of 5* and 5 for research quality, demonstrating excellence at an international level. The University's research grant income places it among the top 20 UK research universities. The University employs over 3,000 people, has an annual turnover of £184m, covers an estate of 94 hectares and is engaged in a £300m investment programme- among the biggest of any UK university.
University of Leicester
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/98768.php>
APA
http://www.medicalnewstoday.com/releases/98768.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



